HITS: Force for Activation

On March 20, 2019, Posted by , In News, By , , With Comments Off on HITS: Force for Activation

 Tumor invasion and metastasis are major problems in the therapy of cancer patients. A team of researchers at the Heidelberg Institute of Theoretical Studies (HITS), the LMU Munich (both Germany) and the CNIO Madrid, Spain, has now elucidated the activation conditions for a key enzyme in this process – a…

KIT: Artificial Intelligence in Medicine

On February 15, 2019, Posted by , In News, By , , With Comments Off on KIT: Artificial Intelligence in Medicine

A new BMBF funded project analyzes opportunities and challenges of Artificial Intelligence, modern human genomics and genome editing.   Treating diseases, “improving” the genetic make-up: Researchers at KIT are investigating what AI can contribute here and what ethical questions it raises (Picture: Pixabay)   Deciphering the human genome is still…

HITS: The state-of-the-art of ‘Molecular Modeling in Drug Design’

On January 23, 2019, Posted by , In News, By , With Comments Off on HITS: The state-of-the-art of ‘Molecular Modeling in Drug Design’

New Special Issue in the journal ‘Molecules’ out on the state-of-the-art of ‘Molecular Modeling in Drug Design’ guest edited by Rebecca Wade (HITS) and Outi Salo-Ahen (Abo Akademi University, Turku, Finland) This Special Issue contains thirteen articles that provide a vivid snapshot of the state-of-the-art of molecular modeling in drug…

AbbVie: towards innovative therapies with “Alfons”

On January 15, 2019, Posted by , In News, By , , With Comments Off on AbbVie: towards innovative therapies with “Alfons”

What does the future of research actually look like? Alfons” gives an answer to this question. What sounds like a first name that has gone out of fashion stands for the finest in high technology. “Automated Liquid Formulation Screening” is a real innovation: Using the data generated with this system,…

DKFZ/EMBL: Algorithm identifies multiple gene–environment relationships

On November 30, 2018, Posted by , In News, By , , With Comments Off on DKFZ/EMBL: Algorithm identifies multiple gene–environment relationships

Researchers at the German Cancer Research Center (DKFZ), EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Wellcome Sanger Institute have developed a new computational method that makes it possible to identify the impact of hundreds of environmental factors on genotype–environment interactions. The method will enhance understanding of relationship between genotype and…

HS-Analysis: how softwares can contribute to cancer treatment development

On August 23, 2018, Posted by , In News, By , , With Comments Off on HS-Analysis: how softwares can contribute to cancer treatment development

Finding a cure to any type of cancer is one of the biggest challenge in medicine. HS-Analysis wants to bring the concer research forward with the help of a software. Read about the plans of Sergey Biniaminov (Managing Director of HS Analysis) in the interview with ka-news (in German).

HITS: New computational method for drug discovery

On July 12, 2018, Posted by , In News, By , , With Comments Off on HITS: New computational method for drug discovery

HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover page of July 2018 issue of the Journal of Chemical Theory and Computation, software is freely available. The graphical image used for the cover of the JCTC . Image:…